Therapeutic drug monitoring of topiramate by liquid chromatography-tandem mass spectrometry

Clinica Chimica Acta

Volumn 411, Issue 9-10, 2010, Pages 729-734

  Matar, Kamal M ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Human plasma; Tandem mass spectrometry; Therapeutic drug monitoring; Topiramate

Indexed keywords

ETHER; TOPIRAMATE;

ACCURACY; ARTICLE; BLOOD SAMPLING; CALIBRATION; DRUG BLOOD LEVEL; DRUG ISOLATION; DRUG MONITORING; DRUG STABILITY; HUMAN; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RELIABILITY; TANDEM MASS SPECTROMETRY;

ANTICONVULSANTS; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; DRUG STABILITY; EPILEPSY; FRUCTOSE; HUMANS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 77950459928     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.02.003     Document Type: Article

References (23)

1. Shank R., Gardocki J., Streeter A., Maryanoff B. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 2000, 41:S3-S9.
2. Lyseng-Williamson K., Yang L. Topiramate: a review of its use in the treatment of epilepsy. Drugs 2007, 67:2231-2236.
3. Guerrini R., Parmeggiani L. Topiramate and its clinical applications in epilepsy. Expert Opin Pharmacother 2006, 7:811-813.
4. Langtry H., Gillis J., Davis R. Topiramate: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 1997, 54:752-753.
5. Johannessen S. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. Epilepsia 1997, 38:S18-S23.
6. Johannessen S., Battino D., Berry D., et al. Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 2003, 25:347-363.
7. Patsalos P., Berry D., Bourgeois B., et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008, 49:1239-1276.
8. Tang P., Miles M., Glauser T., et al. An improved gas chromatography assay for topiramate monitoring in pediatric patients. Ther Drug Monit 2000, 22:195-201.
9. Wolf C., Crooks C., Poklis A. Rapid gas chromatographic procedure for the determination of topiramate in serum. J Anal Toxicol 2000, 24:661-663.
10. Riffitts J., Gisclon L., Stubbs R., Palmer M. A capillary gas chromatographic assay with nitrogen phosphorus detection for the quantification of topiramate in human plasma, urine and whole blood. J Pharm Biomed Anal 1999, 19:363-371.
11. Holland M., Uetz J., Ng K. Automated capillary gas chromatographic assay using flame ionization detection for the determination of topiramate in plasma. J Chromatogr 1988, 433:276-281.
12. Goswami D., Kumar A., Khuroo A., Monif T., Rab S. Bioanalytical LC-MS/MS method validation for plasma determination of topiramate in healthy Indian volunteers. Biomed Chromatogr 2009, 23:1227-1241.
13. Park J., Park Y., Lee M., et al. Determination of plasma topiramate concentration using LC-MS/MS for pharmacokinetic and bioequivalence studies in healthy Korean volunteers. Biomed Chromatogr 2008, 22:822-829.
14. Subramanian M., Birnbaum A., Remmel R. High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry. Ther Drug Monit 2008, 30:347-356.
15. Britzi M., Soback S., Isoherranen N., et al. Analysis of topiramate and its metabolites in plasma and urine of healthy subjects and patients with epilepsy by use of a novel liquid chromatography-mass spectrometry assay. Ther Drug Monit 2003, 25:314-322.
16. Contin M., Riva R., Albani F., Baruzzi A. Simple and rapid liquid chromatographic-turbo ion spray mass spectrometric determination of topiramate in human plasma. J Chromatogr B Biomed Sci Appl 2001, 761:133-137.
17. Chen S., Carvey P. Validation of liquid-liquid extraction followed by flow-injection negative ion electrospray mass spectrometry assay to topiramate in human plasma. Rapid Commun Mass Spectrom 2001, 15:159-163.
18. Chen S., Carvey P. Rapid approach to the quantitative determination of topiramate (2, 3:4, 5-bis-O-(1-methylethylidene)-beta-d-fructopyranose sulfamate) in human plasma by liquid-liquid extraction and flow-injection negative-ion electrospray mass spectrometry. Rapid Commun Mass Spectrom 1999, 13:1980-1984.
19. Shah V., Midha K., Findlay J., et al. Bioanalytical method validation-a revisit with a decade of progress. Pharm Res 2000, 17:1551-1557.
20. Shah V., Midha K., Dighe S., et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Pharm Res 1992, 9:588-592.
21. Müller C., Schäfer P., Störtzl M., Vogt S., Weinmann W. Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries. J Chromatogr B 2002, 773:47-52.
22. Matuszewski B., Constanzer M., Chavez-Eng C. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003, 75:3019-3030.
23. Matar K. Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: application to therapeutic monitoring. J Pharm Biomed Anal 2008, 48:822-828.